DAPA & AbbVie Would Like to Invite You to the Women’s Health Sessions

Scroll down to choose your session!

Wednesday, June 23 at 6 PM CST.
Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain.

One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth of endometrial tissue (similar to the lining of the uterus) outside the uterus, causing pain and/or infertility. ORILISSA (Elagolix)represents the first FDA-approved gonadotropin releasing hormone receptor antagonist in the market, and oral treatment for the management of moderate to severe pain associated with endometriosis in over a decade.

This presentation will provide a brief overview of endometriosis disease state, and clinical trial data for Elagolix, indicated for moderate to severe endometriosis pain (FDA approved July 2018). https://www.rxabbvie.com/pdf/orilissa_pi.pdf


Thursday, June 24 at 6 PM CST.
UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women

Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids have been primarily managed by surgery and are the leading reason for the hysterectomies performed in the U.S. ORIAHNN (Elagolix+Estradiol/NETA) is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

This presentation will provide a brief scientific overview of disease state and clinical trial data for Elagolix+E2/NETA, indicated for heavy menstrual bleeding associated with fibroids (FDA approved May 2020). https://www.rxabbvie.com/pdf/oriahnn_pi.pdf

Click on the date you’d like to join us to register for this event!

Wednesday, March 31, at 6 PM CST

Thursday, April 1, at 12:30 PM CST

Dear DAPA members,

The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area.

We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a diversity of healthcare providers. We as MSLs work to advance R&D in Women’s Health, promoting scientific communications that are fair and balanced and non-promotional in nature. We are here to support all healthcare providers, including pharmacists, deliver the best care to their patients!

Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids have been primarily managed by surgery and are the leading reason for the hysterectomies performed in the U.S. ORIAHNN (Elagolix+Estradiol/NETA) is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

With the ultimate goal to bring awareness, and elevate Women’s healthcare and the scientific acumen of our healthcare givers in our community, I will be offering a virtual educational program to connect with all of you, and provide a brief overview of uterine fibroids disease state and the phase III clinical trial data supporting our newest product indicated for heavy menstrual bleeding associated with uterine fibroids (FDA approved in 2020, https://www.rxabbvie.com/pdf/oriahnn_pi.pdf)

I will be offering two options for you to join via zoom,

Wed Mar 31, at 6 pm CT

Thurs April 1, at 12:30 pm CT

I look forward to having you join!

As your local MSL, please count on me as your local scientific peer and resource.

Thank you for your devoted service to all our patients,


Maria J. Torres, PhD

Medical Science Liaison – Women’s Health | TX MS LA

Women’s Health MSL Organization

US Medical Affairs

BIO: Maria Jose Torres, PhD

Dr. Torres brings 10 years of academic research experience in the Women’s Health arena with a focus on estrogens and estrogen-dependent disease. She completed her bachelor’s degree in Biochemistry in her home country, Uruguay, and then moved to the United States to pursue her Doctorate in Bioenergetics at East Carolina University. Her research work, discovering novel non-genomic mechanisms of metabolic control by estrogens impacted by menopause was published in the top journal Cell, and she was soon recruited to Duke University. Working at the Duke Molecular Physiology Institute, she was a Duke Scholar in Molecular Medicine, she received a Postdoctoral Fellowship through the American Heart Association, and was the developer and leader of a clinical-translational research program to investigate the long-term cardiometabolic toxicity of chemotherapy in breast cancer survivors.

Mission-driven to advance Women’s Health research and healthcare, Dr. Torres recently joined the AbbVie Women’s Health Organization as a Medical Science Liaison, supporting the territory o

DAPA’s December 2020 Meeting – 
Presented by Merck

DAPA would like to invite you to an upcoming virtual program from Merck Oncology, entitled:
Discussing Anti-cancer Therapy Along With Patient Monitoring and Management of Adverse Events.
Below is the speaker presenting for this program.

Dr. Eric Nadler

You will be receiving an email from DAPA with our announcements and updates from DAPA President, Jeff Loesch, before the program.

Understand the mechanism of action of a current anticancer therapy
Identify what to monitor and how to manage adverse reactions associated with an anticancer therapy
Discuss a clinical case highlighting management of selected adverse reactions

Click below to review event dates and to register.

As you click on the link above, you will be able to review the program options and register accordingly. Merck is pleased to sponsor this program. This program is not an accredited CME program and is not designed to meet any training and/or educational requirements.If you have any questions about this event, please email or call me at your convenience. I look forward to speaking with you soon.Regards,Nicole 
+1 (972) 9745722
Felicia Nicole Joe
Merck Customer Representative 

Please remember our pharmacy students!
We are still supporting our students and are still providing scholarships to students in our community!
This meeting is of no charge, but we are still collecting scholarship donations!

DeSoto High School Career Fair – September 12, 2019

DeSoto, TX/DeSoto ISD  (September 12, 2019)Nearly 600 parents and students from elementary school to high school packed DeSoto High School during the district’s College and Career Fair to visit more than 90 colleges, universities, military branches, fraternities, sororities and professional organizations such as DAPA (Dallas Area Pharmacy Association) eager to help connect students to their options after high school.

Our own student liaison, Katherine Chisholm PharmD Candidate Creighton University, has taken the lead in representing pharmacy at the DeSoto High School Career Fair.

She worked with other collaborators in this project to demonstrate to DeSoto high school students what pharmacy is all about!

We want to recognize and thank Katherine Chisholm and all other collaborators that contributed to this project for a wonderful job they have done to shape the future of pharmacy!


Project Collaborators:
Katherine Chisholm (P4 Creighton University)
Judy Chang (P4 University of Austin TX)
Kenny Nguyen (P4 University of Austin TX)
Brenda Muirhead (P2 Creighton University)
Liz Mantsch (P2 Creighton University)
Pablo Gonzales R.Ph (CVS Pharmacy)
Matthew Tran PharmD (CVS Pharmacy
Melanie Smith R.Ph (DAPA Board Member)
Ashley Chasse PharmD (DAPA Board Member)

anonymous photo sharing

You are invited to join the reception honoring Congressman Michael Burges, M.D.

You are invited to join the reception honoring Congressman Michael Burges, M.D.

The favor of a reply is requested by contacting Hetaf Kraydi at 202-549-1010 or by email to hetaf@redriverco.net . Please make checks payable to “Michael Burgess for Congress” and mail P.O. Box 15239 Washington, DC 20003

To RSVP please EMAIL: hetaf@redriverco.net

Download the PDF file .

Legislative Updates

Texas Pharmacy Legislative Updates – TPA & DAPA

This post will have continuous updates on Legislative changes and initiatives from TPA and DAPA.

The Legislative Updates/Snippets are presented by Melanie Smith at every DAPA meeting.

If you have any questions about any of these updates, please meet with Melanie Smith at our meetings, or email her at melaniehopesmith@gmail.com

Pharmacists, Pharmacy Technicians, and Pharmacy Students!
Be a RESOURCE to your Texas Legislators!
Support PharmPAC
Renew & Join TPA!
Look for the NEXT election date!


Download the PDF file .


Download the PDF file .


Download the PDF file .

Presented to DAPA on March 2019 by Melanie Smith:

Texas Pharmacy Day at the Capitol
Since December I have been updating you on Pharmacy Day at the Capitol. Well, it happened! It was ENERGIZING and FUN.

200 pharmacists including DAPA’s own
Melanie Smith, Jamahla Murgerson, Chris Dembny, anyone else?
And 400 students from 7 TX pharmacy schools, including Susan Dembny, UH P2 student and Chris’s daughter,were among the 
600 pharmacy professionals gatheredin Austin on Tuesday, Feb 26 for the Pharmacy Day at the Capitol. It was the biggest Pharmacy Day yet.
The day started at 7:30 AM with TPA’s informative, interactive and organized training session that began with welcomes from TPA ED Debbie Garza and Austin’s own State Sen. Kirk Watson (D-14).  

A lively panel discussion about effective advocacy techniquesfeatured the legislature’s only pharmacist, Sen. Charles Schwertner (R-Georgetown) along with Rep. John Raney (R-College Station) and Rep. Richard Raymond (D-Laredo). 

Association leaders and lobbyists from the TPA and other Texas pharmacy organizations (aka Pharmacy Summit)educated attendees about priority legislation that all Texas pharmacy supports. We concluded the session withrole-played meetings with lawmakers and their staffs in a variety of settings. 

At 10 am, we headed to the south steps of the Capitol for a group photo.

We were showstoppers at the Capitol as the pharmacy professionals in white coats went inside the Capitol building to be recognized on the Texas Senate and House floors. Each chamber declared February 26, 2019 as Texas Pharmacy Day.

We then split into over 25 teams of 1 pharmacist and 1-3 students to meet with our legislators.  TPA did a fantastic job matching constituents and legislators.

Complementing the lobbying efforts was a student led health fair in the Capitol for legislators and their staff members. The students showcased pharmacy’s ability to provide patient-care services beyond dispensing, like point-of-care testing, health screenings, and other educational services.

Each lobbying team received a PACKET  with flyers on the value of pharmacists and issue briefs like the ones we shared last month. I was the team lead with 3 pharmacy students (Niobe of UNT and Zoe and Nick of TX Tech).  We met with our legislators from Dallas County  Representatives John Turner, Julie Johnson, Rafael Anchia and Senator Nathan Johnson and staff. We selected top 3 issues to discuss. The students were apprehensive at first, but once we started talking, they were terrific advocates for pharmacy. The issues we selected were PBM reform, Test and Treat and Furnishing Non-Diagnostic Meds. If we had the time, we also talked about E-scribing and checking PMPs for refills.

At the Jan and Feb DAPA meetings we discussed 9 pharmacy priority issues. The good thing is that 7 of these issues have been filed in the Senate and/or House.  Even better news is that 6 were forwarded to the appropriate committees. And the SB420 Pharmacists’ requirements to check PMP for refill prescriptions had a public hearing and is back as pending in committee. So things are moving much faster than they did in 2017.

Call to action:

  • Check the status of these bills in TPA’s Advocacy Tracking site
  • Advocate for bills impacting pharmacy
  • be a resource to your TX Legislators
  • Tell your story
  • Renew/Join TPA


Download the PDF file .


Download the PDF file .